NCT05015998View on ClinicalTrials.gov

A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register

CompletedOBSERVATIONAL
Enrollment

45,637

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Chronic Kidney Disease
Interventions
OTHER

Non-interventional

Epidemiology of anemia associated with chronic kidney disease, rather than to evaluate specific drugs

Trial Locations (1)

Unknown

SE46001, Stockholm

All Listed Sponsors
lead

Astellas Pharma Europe Ltd.

INDUSTRY

NCT05015998 - A Study to Evaluate the ePidemiology of anEmia Associated With chroNic Kidney Disease in Patients in Primary Care Using The Stockholm CREAtinine Measurement (SCREAM) Register | Biotech Hunter | Biotech Hunter